BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1573041)

  • 1. Theoretical basis for response to steroid suppression in major depression.
    Rothschild AJ; Schatzberg AF
    J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to steroid suppression in major depression resistant to antidepressant therapy.
    Murphy BE; Dhar V; Ghadirian AM; Chouinard G; Keller R
    J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
    Murphy BE; Ghadirian AM; Dhar V
    Can J Psychiatry; 1998 Apr; 43(3):279-86. PubMed ID: 9561317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of major depression with steroid suppressive drugs.
    Murphy BE
    J Steroid Biochem Mol Biol; 1991 Aug; 39(2):239-44. PubMed ID: 1888684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
    Anand A; Malison R; McDougle CJ; Price LH
    Biol Psychiatry; 1995 Mar; 37(5):338-40. PubMed ID: 7748987
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?
    Kling MA; Coleman VH; Schulkin J
    Depress Anxiety; 2009; 26(7):641-9. PubMed ID: 19133699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman.
    Ravaris CL; Sateia MJ; Beroza KW; Noordsy DL; Brinck-Johnsen T
    Arch Gen Psychiatry; 1988 Oct; 45(10):966-7. PubMed ID: 3262333
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of major depression with metyrapone and hydrocortisone.
    O'Dwyer AM; Lightman SL; Marks MN; Checkley SA
    J Affect Disord; 1995 Feb; 33(2):123-8. PubMed ID: 7759660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiglucocorticoid therapies in major depression: a review.
    Murphy BE
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S125-32. PubMed ID: 9264159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of depression with antiglucocorticoid drugs.
    Wolkowitz OM; Reus VI
    Psychosom Med; 1999; 61(5):698-711. PubMed ID: 10511017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.
    Ghadirian AM; Engelsmann F; Dhar V; Filipini D; Keller R; Chouinard G; Murphy BE
    Biol Psychiatry; 1995 Mar; 37(6):369-75. PubMed ID: 7772645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effects of cortisol synthesis inhibition on treatment-resistant depression].
    Iizuka H; Kishimoto A; Nakamura J; Mizukawa R
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):33-6. PubMed ID: 8640461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles.
    Raven PW; O'Dwyer AM; Taylor NF; Checkley SA
    Psychoneuroendocrinology; 1996 Apr; 21(3):277-86. PubMed ID: 8817726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole therapy for atypical depression.
    Sovner R; Fogelman S
    J Clin Psychiatry; 1996 May; 57(5):227-8. PubMed ID: 8626356
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR; Ross W; Hall R; Cook DB
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract]   [Full Text] [Related]  

  • 18. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M; De Ruyter M; Suy E
    Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances.
    Obinata D; Yamaguchi K; Hirano D; Yoshida T; Soma M; Takahashi S
    Int J Urol; 2008 Apr; 15(4):361-2. PubMed ID: 18380829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metyrapone and aminoglutethimide on the murine sarcoma (MuSV-M) and breast adenocarcinoma (C3HBA).
    Seifter E; Critselis AN; Levenson SM; Rettura G
    J Surg Oncol; 1979; 12(3):281-8. PubMed ID: 228124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.